The Long and Short of It: New Lessons on the Optimal Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer and Where We Need to Go From Here
Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1014-1017.
doi: 10.1016/j.ijrobp.2018.01.063.